loading
前日終値:
$1.31
開ける:
$1.33
24時間の取引高:
11.56M
Relative Volume:
1.36
時価総額:
$348.10M
収益:
$188.87M
当期純損益:
$-400.38M
株価収益率:
-0.8467
EPS:
-1.5
ネットキャッシュフロー:
$-260.90M
1週間 パフォーマンス:
+5.83%
1か月 パフォーマンス:
+24.51%
6か月 パフォーマンス:
-35.53%
1年 パフォーマンス:
-19.11%
1日の値動き範囲:
Value
$1.23
$1.34
1週間の範囲:
Value
$1.16
$1.40
52週間の値動き範囲:
Value
$0.8511
$2.72

Pacific Biosciences Of California Inc Stock (PACB) Company Profile

Name
名前
Pacific Biosciences Of California Inc
Name
セクター
Healthcare (1174)
Name
電話
650-521-8000
Name
住所
1305 O'BRIEN DRIVE, MENLO PARK, CA
Name
職員
575
Name
Twitter
@pacbio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PACB's Discussions on Twitter

PACB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
PACB
Pacific Biosciences Of California Inc
1.27 348.10M 188.87M -400.38M -260.90M -1.50
Medical Devices icon
ABT
Abbott Laboratories
132.99 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
101.30 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
375.56 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
86.34 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
73.83 44.46B 5.54B 4.18B 623.10M 7.00

Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-11 ダウングレード UBS Buy → Neutral
2024-06-03 再開されました Jefferies Buy
2024-04-22 ダウングレード JP Morgan Overweight → Neutral
2024-04-18 ダウングレード Goldman Buy → Neutral
2023-12-14 開始されました Guggenheim Neutral
2023-12-14 開始されました Stephens Overweight
2023-12-13 開始されました Wolfe Research Peer Perform
2023-11-17 アップグレード UBS Neutral → Buy
2023-10-31 アップグレード Cantor Fitzgerald Neutral → Overweight
2023-09-28 開始されました Bernstein Outperform
2023-07-05 再開されました JP Morgan Overweight
2023-06-30 開始されました Goldman Buy
2023-05-10 開始されました Barclays Equal Weight
2023-03-31 アップグレード TD Cowen Market Perform → Outperform
2023-02-02 開始されました UBS Neutral
2023-01-20 ダウングレード Cantor Fitzgerald Overweight → Neutral
2023-01-05 開始されました Scotiabank Sector Outperform
2022-01-21 再開されました Cantor Fitzgerald Overweight
2022-01-06 再開されました Piper Sandler Neutral
2021-10-15 再開されました Cowen Market Perform
2021-09-27 開始されました Canaccord Genuity Buy
2021-02-11 アップグレード Piper Sandler Neutral → Overweight
2020-11-03 ダウングレード Piper Sandler Overweight → Neutral
2020-10-02 アップグレード JP Morgan Neutral → Overweight
2020-09-09 開始されました Morgan Stanley Equal-Weight
2020-06-02 再開されました Cantor Fitzgerald Overweight
2020-03-09 再開されました Cantor Fitzgerald Overweight
2019-10-15 アップグレード Piper Jaffray Neutral → Overweight
2019-04-02 ダウングレード Stephens Overweight → Equal-Weight
2018-10-19 開始されました Cowen Outperform
2017-11-03 ダウングレード First Analysis Sec Overweight → Equal-Weight
2017-09-28 ダウングレード CL King Buy → Neutral
2016-11-03 繰り返されました Cantor Fitzgerald Buy
2016-06-27 開始されました CL King Buy
2016-04-15 開始されました First Analysis Sec Overweight
2016-02-04 ダウングレード Piper Jaffray Overweight → Neutral
2016-01-04 繰り返されました Cantor Fitzgerald Buy
2015-10-23 アップグレード Piper Jaffray Neutral → Overweight
2015-08-27 開始されました Cantor Fitzgerald Buy
2015-02-04 繰り返されました Maxim Group Buy
2013-09-26 繰り返されました Maxim Group Buy
2013-01-14 繰り返されました Maxim Group Buy
すべてを表示

Pacific Biosciences Of California Inc (PACB) 最新ニュース

pulisher
Jun 12, 2025

Here's Why You Should Add PacBio Stock to Your Portfolio Now - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Following a 41% decline over last year, recent gains may please Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional owners - simplywall.st

Jun 12, 2025
pulisher
Jun 12, 2025

Celebrating Father’s Day with new discoveries of the Y chromosome achieved with HiFi sequencing - PacBio

Jun 12, 2025
pulisher
Jun 11, 2025

Transcript : Pacific Biosciences of California, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 10 - MarketScreener

Jun 11, 2025
pulisher
Jun 10, 2025

PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds - Yahoo Finance

Jun 10, 2025
pulisher
Jun 06, 2025

Pacific Biosciences Approves Key Proposals at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

Powered by PacBio: Selected publications from May 2025 - PacBio

Jun 05, 2025
pulisher
Jun 05, 2025

Pacific Biosciences Of California To Present At Jefferies Conference; Webcast At 8:45 AM ET - Nasdaq

Jun 05, 2025
pulisher
Jun 04, 2025

Amgen To Present At Jefferies Healthcare Conference; Webcast At 9:20 AM ET - Nasdaq

Jun 04, 2025
pulisher
Jun 04, 2025

Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Pacific Biosciences of California, Target ALS Collaborate for Genomic Study - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

PacBio (PACB) Joins Forces with Target ALS for Major Genomic Study | PACB Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Pacific Biosciences of California: Sell Before Potential Reverse Split - Seeking Alpha

Jun 02, 2025
pulisher
May 31, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Pacific Biosciences of California, Inc. (PACB) Regarding Possible Securities Fraud Violations - ACCESS Newswire

May 31, 2025
pulisher
May 30, 2025

Media resourceS - PacBio

May 30, 2025
pulisher
May 29, 2025

All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy - sharewise

May 29, 2025
pulisher
May 29, 2025

PureTarget repeat expansion and carrier panels enable high-throughput clinical research solutions - PacBio

May 29, 2025
pulisher
May 28, 2025

PacBio to Present at Upcoming Investor Conferences - Yahoo Finance

May 28, 2025
pulisher
May 25, 2025

Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Call Transcript - MSN

May 25, 2025
pulisher
May 23, 2025

PacBio Stock Slips Despite New China Distribution Deal With Haorui - sharewise

May 23, 2025
pulisher
May 22, 2025

PACB stock touches 52-week low at $0.94 amid market challenges - Investing.com Australia

May 22, 2025
pulisher
May 22, 2025

PacBio (PACB) Expands Presence in China with New Distribution De - GuruFocus

May 22, 2025
pulisher
May 22, 2025

PacBio (PACB) Expands Presence in China with New Distribution Deal | PACB Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

HiFi sequencing uncovers the secret to aging gracefully in Earth’s oldest living organisms - PacBio

May 22, 2025
pulisher
May 20, 2025

Pacific Biosciences: A Mountain Of Red Flags (NASDAQ:PACB) - Seeking Alpha

May 20, 2025
pulisher
May 16, 2025

Potential Upside For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Not Without Risk - simplywall.st

May 16, 2025
pulisher
May 16, 2025

PACB: Piper Sandler Adjusts Price Target for Pacific Biosciences - GuruFocus

May 16, 2025
pulisher
May 15, 2025

PACB: Piper Sandler Adjusts Price Target for Pacific Biosciences | PACB Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

PACB: Stephens & Co. Reiterates Overweight Rating | PACB Stock N - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Where Pacific Biosciences Stands With Analysts - Benzinga

May 15, 2025
pulisher
May 15, 2025

PACB: Stephens & Co. Reiterates Overweight Rating | PACB Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

PACB Price Target Reduced by Piper Sandler Following Quarterly R - GuruFocus

May 15, 2025
pulisher
May 15, 2025

PACB Price Target Reduced by Piper Sandler Following Quarterly Results | PACB Stock News - GuruFocus

May 15, 2025
pulisher
May 14, 2025

PacBio clears allegations after special investigation By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Metagenomics Market Size, Share, Forecast & Trends Analysis Report 2025: Market to Soar to $6.71 Billion by 2031, Driven by Agri Genomics and Genome Mapping - GlobeNewswire Inc.

May 14, 2025
pulisher
May 12, 2025

PACB Stock May Rise Following the Deal With Chulalongkorn University - Nasdaq

May 12, 2025
pulisher
May 12, 2025

PacBio (PACB) Completes Probe into Employment Practices and Cybe - GuruFocus

May 12, 2025
pulisher
May 12, 2025

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated - Yahoo Finance

May 12, 2025
pulisher
May 12, 2025

Pacbio adjusts 2025 revenue guidance to $150M-$170M amid macroeconomic challenges - MSN

May 12, 2025
pulisher
May 10, 2025

Pacific Biosciences of California First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance

May 10, 2025
pulisher
May 09, 2025

PacBio (PACB) Sees Increased Options Activity Ahead of Earnings - GuruFocus

May 09, 2025
pulisher
May 09, 2025

PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates - Yahoo Finance

May 09, 2025

Pacific Biosciences Of California Inc (PACB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Pacific Biosciences Of California Inc (PACB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
HENRY CHRISTIAN O
See Remarks
Mar 03 '25
Sale
1.41
12,497
17,583
2,225,357
Van Oene Mark
See Remarks
Mar 03 '25
Sale
1.41
6,486
9,126
1,497,695
Farmer Michele
See Remarks
Mar 03 '25
Sale
1.41
2,973
4,183
184,619
$303.15
price up icon 0.45%
medical_devices PHG
$22.29
price up icon 1.04%
medical_devices STE
$235.67
price down icon 0.24%
$80.00
price down icon 1.25%
$71.28
price down icon 0.85%
medical_devices EW
$73.83
price down icon 0.20%
大文字化:     |  ボリューム (24 時間):